1. Vedolizumab is effective and safe in elderly inflammatory bowel disease patients: a binational, multicenter, retrospective cohort study. Issue 9 (1st November 2020) Authors: Cohen, Nathaniel Aviv; Plevris, Nikolas; Kopylov, Uri; Grinman, Anna; Ungar, Bella; Yanai, Henit; Leibovitzh, Haim; Isakov, Naomi Fliss; Hirsch, Ayal; Ritter, Einat; Ron, Yulia; Shitrit, Ariella Bar‐Gil; Goldin, Eran; Dotan, Iris; Horin, Shomron Ben; Lees, Charlie W; Maharshak, Nitsan Journal: United European Gastroenterology journal Issue: Volume 8:Issue 9(2020) Page Start: 1076 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Vedolizumab is effective and safe in elderly inflammatory bowel disease patients: a binational, multicenter, retrospective cohort study. Issue 9 (November 2020) Authors: Cohen, Nathaniel Aviv; Plevris, Nikolas; Kopylov, Uri; Grinman, Anna; Ungar, Bella; Yanai, Henit; Leibovitzh, Haim; Isakov, Naomi Fliss; Hirsch, Ayal; Ritter, Einat; Ron, Yulia; Shitrit, Ariella Bar-Gil; Goldin, Eran; Dotan, Iris; Horin, Shomron Ben; Lees, Charlie W; Maharshak, Nitsan Journal: United European Gastroenterology journal Issue: Volume 8:Issue 9(2020) Page Start: 1076 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗